The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors

BACKGROUND: The clinical trials using immunotherapy have been performed for the treatment of variety of malignant tumors. However, large-scale meta-analysis of combined DC-CTL/CIK therapy on immune and clinical response in patients has not been well studied yet. The purpose of this study is to inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ying, Xu, Zenghui, Zhou, Fuping, Sun, Yan, Chen, Jingbo, Li, Linfang, Jin, Huajun, Qian, Qijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641330/
https://www.ncbi.nlm.nih.gov/pubmed/26561538
http://dx.doi.org/10.1186/s40164-015-0027-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641330/
https://www.ncbi.nlm.nih.gov/pubmed/26561538
http://dx.doi.org/10.1186/s40164-015-0027-9

Ejemplares similares